1 |
Robert A, Smith VC, Brooks D, et al. Cancer screening in the United States, 2010: A review of current American Cancer Society Guidelines and issues in cancer screening[J]. CA Cancer J Clin,2010,60:99-119.
|
2 |
Wang LH, Qiu X, Zheng RM, et al. Review and prospect on prevent strategy and epidemiology of cervical cancer in China[J]. Chin J Women Child Health, 2010, 1(3): 145-149.
|
3 |
Meng RL, Ma WJ, Xu YJ, et al. Influence factors and scanning rate of breast and cervical cancer of women in Guangdong[J]. South China J Prevent Med, 2010, 36(2): 8-10, 14.
|
4 |
Li B, Zhang XZ, Luo XP, et al. Evaluation of variable cervical cancer screening methods effectiveness in rural areas of Chaozhou city, Guangdong province[J]. Chin J Obstet Gynecol Pediatr:Electron Ed, 2013, 9(1):30-36.
|
5 |
Sherris J, Wittet S, Kleine A, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings[J]. Int Perspect Sexual Reproduct Health,2009, 35(3):35(3):147-54.
|
6 |
McAdam M, Sakita J, Tarivonda L, et al. Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting[J]. PLoS ONE, 2010, 5(10):e13266.
|
7 |
Jiang M, Yu M. Health economics evaluation and application of high risk human papilloma virus in cervical cancer scanning[J]. Int J Patholog Clin Med, 2012, 30(4): 351-354.
|
8 |
Wang J, Fang GX, Liu JX. Relative factors on HPV infected in women in Huairou[J]. Beijing Med J, 2011,33(5):442-443.
|
9 |
Yang YB, Liu D, Zeng HT. Influence factors on HPV infected and type in women in Guangzhou[J]. Chin J Public Health,2012,28(3):365-367.
|
10 |
Yang GF, Relative factors and prevention on HPV infected[J]. Chin Med Engineering,2010,17(2):133-134.
|
11 |
Yu YY, Jin Z, Huang WL, et al. Risk factors on high risk HPV cervical infected[J]. Chin J Difficult Complicat Cases, 2012,11(5):385-387.
|
12 |
Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening[J]. CA Cancer J Clin,2009, 59: 27-41.
|
13 |
Grce M. Primary and secondary prevention of cervical cancer[J]. Exp Rev Mol Diagn, 2009, 9(8):851-857.
|
14 |
Peng X, Hu LN. HPV infected and it's risk factors[J]. J Pract Obstet Gynecol, 2010,26(3):168-170.
|
15 |
Li LK, Dai M, Clifford GM, et al. Human papillomavirus infection in Shenyang city, People's Republic of China: A population-based study[J]. Br J Cancer, 2006,95(11):1593-1597.
|
16 |
Vinodhini K, Shanmughapriya S, Das BC, et al. Prevalence and risk factors of HPV infection among women from various provinces of the world[J]. J Arch Gynecol Obstet, 2012, 285(3):771-777.
|
17 |
Rachel L. Winer SLJP. Genital human papillomavirus infection incidence and risk factors in a cohort of female university students[J].J Am Epidemiol,2003,157(3):218-226.
|
18 |
Zhang X, Wang CY, Shi JF, et al. Study on the prevalence of human papillomavirus infection and distribution of type in Shenyang city[J]. Chin J Epidemiol, 2007,28(10):954-957.
|
19 |
Yang YB, Liu D, Zeng HT. Risk factors and genotype of HPV infection among women in Guangzhou city[J]. Chin J Public Health, 2012,28(3):365-367.
|
20 |
Roset Bahmanyar E, Paavonen J, Naud P, et al. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational patricia trial[J]. Gynecol Oncol,2012,30: S0090-8258.
|
21 |
Nowicki A, Borowa I, Maruszak M. Women health behaviours regarding prevention and early detection of precancerous lesions and cervical carcinoma[J]. J Ginekologia Polska,2008,79(12):840.
|
22 |
Magnusson PK, Gyllensten UB. Cervical cancer risk: Is there a genetic component[J]? J Mol Med Today, 2000, 6(4):145-148.
|
24 |
Liu JH, Guan MF, Qian DY, et al. Study on cervical intraepithelial neoplasia in relation to human papillomavirus and co-factors: A case-control study in China and Australia[J]. Chin J Epidemiol,2007,28(10):958-963.
|